zintick

TransMedics Group TMDX

TransMedics Group, Inc. · Nasdaq · Electromedical & Electrotherapeutic Apparatus

$92.01+1.17%close on Nov. 11, 2026 · volume 914K · Yahoo Finance

Price, last 57 sessions

$70.00$80.00$90.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 11, 2026 · high $93.79 · low $65.99 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 11, 2026David Weill
director
Bought1,336$81.63$109,058

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 8 →
  • 10-QNov. 5, 2026, 4:10 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 4:02 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedTransMedics Beats Q3 2026 Estimates With Adjusted EPS of $0.51 vs $0.29 Consensus and Raises FY2026 Revenue Guidance to $764-$774 Million

  • 4Oct. 30, 2026, 4:15 p.m. ETView on SEC.gov
  • 4Sept. 14, 2026, 4:30 p.m. ETView on SEC.gov
  • 8-KSept. 10, 2026, 4:40 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

  • 4Aug. 17, 2026, 4:45 p.m. ETView on SEC.gov
  • 10-QAug. 4, 2026, 4:15 p.m. ETView on SEC.gov
  • 8-KAug. 4, 2026, 4:05 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits